These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4867941)

  • 41. Heterogeneity of Clstridium botulinum type A toxin.
    Hauschild AH; Hilsheimer R
    Can J Microbiol; 1968 Jul; 14(7):805-7. PubMed ID: 4879302
    [No Abstract]   [Full Text] [Related]  

  • 42. Purification of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):220-7. PubMed ID: 3293334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The fractional composition of the toxins and anatoxins of Cl. oedematiens. I. Fractionation of the toxins and anatoxins by the gel filtration method].
    Kulak VG; Golshmid VK; Nenashev VP; Glushkova AI; Ianishevskaia MN
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Jun; 47(6):112-5. PubMed ID: 5495122
    [No Abstract]   [Full Text] [Related]  

  • 44. Ganglioside inactivation of botulinum toxin.
    Simpson LL; Rapport MM
    J Neurochem; 1971 Jul; 18(7):1341-3. PubMed ID: 4330291
    [No Abstract]   [Full Text] [Related]  

  • 45. Proteases of Clostridium botulinum. 3. Isolation and characterization of proteases from Clostridium botulinum types A,B,C,D and F.
    Tjaberg TB
    Acta Vet Scand; 1973; 14(4):538-59. PubMed ID: 4585531
    [No Abstract]   [Full Text] [Related]  

  • 46. [Purification and complementary analysis of the thermostable toxin of B. thuringiensis var. thuringiensis].
    de Barjac H; Dedonder R
    Bull Soc Chim Biol (Paris); 1968; 50(4):941-4. PubMed ID: 5675533
    [No Abstract]   [Full Text] [Related]  

  • 47. [A study of botulin toxins and anatoxins by the gel filtration method. 3. Separation of native botulin toxins types B and C by filtration through Sephadex G-200 gel].
    Freĭman VB; Golshmid VK; Mikhailova IM; Chentsova OI
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Nov; 44(11):139-42. PubMed ID: 5616100
    [No Abstract]   [Full Text] [Related]  

  • 48. Autolytic enzyme system of Clostridium botulinum. II. Mode of action of autolytic enzymes in Clostridium botulinum type A.
    Takumi K; Kawata T; Hisatsune K
    Jpn J Microbiol; 1971 Mar; 15(2):131-41. PubMed ID: 4930808
    [No Abstract]   [Full Text] [Related]  

  • 49. Purification and amino acid composition of type A botulinum neurotoxin.
    DasGupta BR; Sathyamoorthy V
    Toxicon; 1984; 22(3):415-24. PubMed ID: 6382680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conformational studies on modified proteins and peptides. VII. Conformation of epsilon-prototoxin and epsilon-toxin from Clostridium perfringens. Conformational changes associated with toxicity.
    Habeeb AF; Lee CL; Atassi MZ
    Biochim Biophys Acta; 1973 Oct; 322(2):245-50. PubMed ID: 4358084
    [No Abstract]   [Full Text] [Related]  

  • 51. Dissociation of Clostridium botulinum type-E-toxin.
    Kitamura M; Sakaguchi S; Sakaguchi G
    Biochem Biophys Res Commun; 1967 Dec; 29(6):892-7. PubMed ID: 4965663
    [No Abstract]   [Full Text] [Related]  

  • 52. [Study of leukotoxic activity of Cl. perfringens type A toxin and its fractions obtained by gel filtration and ion exchange chromatography].
    Tselukh AV; Protchenko PZ; Golovatiuk AL
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jul; (7):119-23. PubMed ID: 188277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative sizes of type A and B botulinum neurotoxins.
    DasGupta BR; Sugiyama H
    Toxicon; 1977; 15(4):357-63. PubMed ID: 882998
    [No Abstract]   [Full Text] [Related]  

  • 54. Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile.
    Banno Y; Kobayashi T; Kono H; Watanabe K; Ueno K; Nozawa Y
    Rev Infect Dis; 1984; 6 Suppl 1():S11-20. PubMed ID: 6426016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Snake venom toxins. The amino acid sequence of three toxins (CM-2e, CM-4a and CM-) from Naja haje annulifera (Egyptian cobra) venom.
    Joubert FJ
    Hoppe Seylers Z Physiol Chem; 1976 Dec; 357(12):1735-50. PubMed ID: 1017800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amino acid composition of Clostridium botulinum type A toxin.
    Alstyne DV; Gerwing J; Tremaine JH
    J Bacteriol; 1966 Sep; 92(3):796-7. PubMed ID: 5332083
    [No Abstract]   [Full Text] [Related]  

  • 57. Purification and characterization of Clostridium botulinum type B oxin.
    Gerwing J; Dolman CE; Kason DV; Tremaine JH
    J Bacteriol; 1966 Feb; 91(2):484-7. PubMed ID: 5327476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Amino acid composition of major components of Cl. botulinum toxin of type B].
    Kliucheva VV; Saprykina TP; Dolgikh MS; Blagoveshchenskiĭ VA
    Vopr Med Khim; 1982; 28(5):29-33. PubMed ID: 6758340
    [No Abstract]   [Full Text] [Related]  

  • 59. RECENT OBSERVATION ON THE GROWTH AND TOXIN PRODUCTION OF CLOSTRIDIUM BOTULINUM TYPE E.
    IIDA H
    Jpn J Med Sci Biol; 1963 Oct; 16():307-9. PubMed ID: 14090795
    [No Abstract]   [Full Text] [Related]  

  • 60. Characterization of toxin complex produced by a unique strain of Clostridium botulinum serotype D 4947.
    Hasegawa K; Watanabe T; Sato H; Sagane Y; Mutoh S; Suzuki T; Yamano A; Kouguchi H; Takeshi K; Kamaguchi A; Fujinaga Y; Oguma K; Ohyama T
    Protein J; 2004 Aug; 23(6):371-8. PubMed ID: 15517984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.